These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Role of all-trans-retinoic acid (ATRA) in the consolidation therapy of acute promyelocytic leukaemia (APL). Gupta V; Yi QL; Brandwein J; Lipton JH; Messner HA; Schuh AC; Wells RA; Minden MD Leuk Res; 2005 Jan; 29(1):113-4. PubMed ID: 15541484 [TBL] [Abstract][Full Text] [Related]
9. Thrombosis in patients with acute promyelocytic leukemia treated with and without all-trans retinoic acid. Escudier SM; Kantarjian HM; Estey EH Leuk Lymphoma; 1996 Feb; 20(5-6):435-9. PubMed ID: 8833399 [TBL] [Abstract][Full Text] [Related]
10. Comparison of anthracycline-based combination chemotherapy with or without all-trans retinoic acid in acute promyelocytic leukemia. Raza S; Ullah K; Ahmed P; Khan B J Coll Physicians Surg Pak; 2008 Sep; 18(9):546-50. PubMed ID: 18803891 [TBL] [Abstract][Full Text] [Related]
11. Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry. Lehmann S; Ravn A; Carlsson L; Antunovic P; Deneberg S; Möllgård L; Derolf AR; Stockelberg D; Tidefelt U; Wahlin A; Wennström L; Höglund M; Juliusson G Leukemia; 2011 Jul; 25(7):1128-34. PubMed ID: 21502956 [TBL] [Abstract][Full Text] [Related]
12. Use of all-trans retinoic acid in combination with arsenic trioxide for remission induction in patients with newly diagnosed acute promyelocytic leukemia and for consolidation/maintenance in CR patients. Dai CW; Zhang GS; Shen JK; Zheng WL; Pei MF; Xu YX; Cao YX; Yi Y; Yang JJ; Peng HL; Zhong HY; Li RJ Acta Haematol; 2009; 121(1):1-8. PubMed ID: 19246888 [TBL] [Abstract][Full Text] [Related]
13. Combined therapy with all-trans-retinoic acid and high-dose chemotherapy in patients with hyperleukocytic acute promyelocytic leukemia and severe visceral hemorrhage. Dombret H; Sutton L; Duarte M; Daniel MT; Leblond V; Castaigne S; Degos L Leukemia; 1992 Dec; 6(12):1237-42. PubMed ID: 1453767 [TBL] [Abstract][Full Text] [Related]
14. [Hemostatic changes during the treatment of acute promyelocytic leukemia with all-transretinoic acid]. Medvedeva NA; Cherepanova VV; Tarasova LN; Kudriavtseva AV; Kostin AI; Kolupaeva OR Ter Arkh; 2000; 72(7):27-31. PubMed ID: 10983317 [TBL] [Abstract][Full Text] [Related]
15. The efficacy and safety of arsenic trioxide with or without all-trans retinoic acid for the treatment of acute promyelocytic leukemia: a meta-analysis. Wang H; Chen XY; Wang BS; Rong ZX; Qi H; Chen HZ Leuk Res; 2011 Sep; 35(9):1170-7. PubMed ID: 21774985 [TBL] [Abstract][Full Text] [Related]
16. Treatment with all-trans retinoic acid in acute promyelocytic leukemia reduces early deaths in children. Mann G; Reinhardt D; Ritter J; Hermann J; Schmitt K; Gadner H; Creutzig U Ann Hematol; 2001 Jul; 80(7):417-22. PubMed ID: 11529468 [TBL] [Abstract][Full Text] [Related]
17. Early onset of chemotherapy can reduce the incidence of ATRA syndrome in newly diagnosed acute promyelocytic leukemia (APL) with low white blood cell counts: results from APL 93 trial. de Botton S; Chevret S; Coiteux V; Dombret H; Sanz M; San Miguel J; Caillot D; Vekhoff A; Gardembas M; Stamatoulas A; Conde E; Guerci A; Gardin C; Fey M; Cony Makhoul D; Reman O; de la Serna J; Lefrere F; Chomienne C; Degos L; Fenaux P; Leukemia; 2003 Feb; 17(2):339-42. PubMed ID: 12592333 [TBL] [Abstract][Full Text] [Related]
18. Delay in the administration of all-trans retinoic acid and its effects on early mortality in acute promyelocytic leukemia: final results of a multicentric study in the United States. Rashidi A; Riley M; Goldin TA; Sayedian F; Bayerl MG; Aguilera NS; Vos JA; Goudar RK; Fisher SI Leuk Res; 2014 Sep; 38(9):1036-40. PubMed ID: 25035073 [TBL] [Abstract][Full Text] [Related]
19. Occurrence of cerebellar thrombohemorrhage during all-trans retinoic acid (ATRA) therapy in a case of acute promyelocytic leukemia. Parma M; Casaroli I; Pogliani EM Haematologica; 1996; 81(4):379-80. PubMed ID: 8870387 [No Abstract] [Full Text] [Related]